Acetylon Pharmaceuticals raised a round of funding on July 30, 2013. Investors include Celgene.
Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human disease…
